KinoPharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Tokyo, Japan. The company focuses on researching and developing innovative small-molecule drugs based on novel concepts to address major medical needs, such as antiviral treatments.
Subscribe to see KinoPharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
KinoPharma is a biotech company headquartered in Tokyo, Japan. Its most recent funding round closed in July 2023. Xcout tracks 9 named people at KinoPharma, including 中村 正徳 (執行役員 経営管理部長CFO).
As of 16 November 2026. Source: Xcout Intel.
3 more named people on record for KinoPharma, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | Undisclosed | 3 named | |
| Corporate Minority | Undisclosed | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of KinoPharma's closest competitors — see the full list of competitors and alternatives →
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Carlsbad, California. The company focuses on the development of novel oral antiviral treatments for viral diseases.
Kinaset Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing novel therapeutics.
Qpex Biopharma, Inc. is a biopharmaceutical company located in San Diego, California, specializing in infectious disease solutions as part of the Shionogi Group.
Chordia Therapeutics Inc. is a clinical-stage Japanese drug discovery venture company headquartered in Japan, engaged in the research and development of novel targeted anticancer therapeutics.
Red Queen Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on antiviral therapeutics, with its headquarters located in Cambridge, Massachusetts.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about KinoPharma? Suggest a correction · Work at KinoPharma? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.